Product Description: Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Huizinga TWJ, et, al. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis. Arthritis Res Ther. 2017 Mar 9;19(1):53.
CAS Number: 1206681-39-1
Molecular Weight: N/A
Compound Purity: 99.47
Research Area: Inflammation/Immunology
Solubility: H2O
Target: c-Fms